| Literature DB >> 35291712 |
Hirooki Higami1, Hiroaki Matsuda2, Hikaru Tateyama3, Yoriyasu Suzuki2, Kazuaki Kaitani1.
Abstract
Background: Severely calcified coronary artery stenting remains a challenge due to stent thrombosis, target vessel failure, and higher mortality. Moreover, optimal vessel preparation for calcified plaque with a crack formation pattern has not been established yet. We aimed to identify the effect of crack formation in calcified plaque in the coronary artery on the lumen area after stenting. Materials andEntities:
Mesh:
Year: 2022 PMID: 35291712 PMCID: PMC8898875 DOI: 10.1155/2022/7821956
Source DB: PubMed Journal: J Interv Cardiol ISSN: 0896-4327 Impact factor: 2.279
Figure 1Crack formation pattern of calcified plaque. (a) Type 0, no cracks or injury in the vessel. (b, c) Type 1, with crack in calcified plaque (yellow arrowhead) or intima injury (red arrowhead) without medial dissection between calcified plaque and vessel wall. (d) Type 2, with crack in calcified plaque with medial dissection between calcified plaque and vessel wall (blue arrowhead).
Baseline clinical characteristics.
| Variable |
|
|---|---|
| Age (years) | 74.9 ± 7.9 |
| Male | 34 (68%) |
| BMI (kg/m2) | 23.4 ± 3.8 |
| Hypertension | 46 (92%) |
| Dyslipidemia | 36 (72%) |
| Current smoker | 9 (18%) |
| Diabetes mellitus | 27 (54%) |
| Atrial fibrillation | 4 (8%) |
| LVEF (%) | 63.8 ± 12.2 |
| ESRD on HD | 3 (6%) |
| eGFR≤60 without HD (mL/min/1.73 m2) | 25 (50%) |
| PAD | 6 (12%) |
| COPD | 1 (2%) |
| Aortic disease | 1 (2%) |
| Prior PCI | 21 (42%) |
| Prior CABG | 2 (4%) |
| Prior stroke | 6 (12%) |
| CHF | 7 (14%) |
| Prior MI | 18 (36%) |
| SYNTAX score | 21.5 ± 22.9 |
| SYNTAX2 score (PCI) | 34.3 ± 15.9 |
| Acute coronary syndrome | 5 (10%) |
| Multivessel disease | 27 (54%) |
|
| |
| Medications | |
| Aspirin | 49 (98%) |
| Thienopyridine | 50 (100%) |
| OAC | 5 (10%) |
| Statins | 43 (86%) |
|
| 25 (50%) |
| ACE-I/ARB | 30 (60%) |
Data are presented as number (%) or mean ± standard deviation, unless otherwise noted. ACE-I, angiotensin-converting-enzyme inhibitor; ARB, angiotensinI receptor blocker; BMI, body mass index; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HD, hemodialysis; LVEF, left ventricular ejection fraction; MI, myocardial infarction; OAC, oral anticoagulants; PAD, peripheral artery disease; PCI, percutaneous coronary intervention.
Baseline lesion characteristics and procedure details.
| Variable |
|
|---|---|
| Target vessel | |
| Isolated LMCA | 0 |
| LMCA + LAD | 2 (3.7%) |
| LAD | 39 (72%) |
| LCx | 2 (3.7%) |
| RCA | 11 (20%) |
| Lesion length (mm) | 35.0 ± 15.9 |
| Tortuous vessel | 12 (22%) |
| CTO | 0 |
| Rotational atherectomy | 44 (81%) |
| CB diameter (mm) | 2.74 ± 0.31 |
| Maximum pressure of CB dilatation (atm) | 10.4 ± 2.98 |
| Rotablator burr size (mm) † | 1.78 ± 0.20 |
| Slow flow/no reflow during procedure | 5 (9.3%) |
Data are presented as number (%) or mean ± standard deviation, unless otherwise noted. CTO, chronic total occlusion; LAD, left anterior descending artery; LCx, left circumflex artery; LMCA, left main coronary artery; RCA, right coronary artery; CB, cutting balloon. †Calculated in 44 lesions.
OFDI analysis.
| Variable | Type 0 ( | Type 1 ( | Type 2 ( |
|
|---|---|---|---|---|
| Estimated vessel diameter (mm) | 4.05 ± 0.49 | 4.09 ± 0.51 | 3.89 ± 0.46 | 0.01 |
| Estimated vessel area (mm2) | 13.04 ± 3.26 | 13.27 ± 3.17 | 12.03 ± 2.74 | 0.01 |
| Major axis diameter before using CB (mm) | 2.36 ± 0.37 | 2.29 ± 0.37 | 2.11 ± 0.46 | 0.0004 |
| Minor axis diameter before using CB (mm) | 1.79 ± 0.31 | 1.72 ± 0.31 | 1.57 ± 0.31 | 0.0001 |
| Lumen area before using CB (mm2) | 3.37 ± 1.02 | 3.10 ± 0.91 | 2.73 ± 1.01 | 0.0003 |
| Calcium arc (°) | 251 ± 56 | 294 ± 62 | 277 ± 53 | 0.0001 |
| Calcium arc 315–360° | 8 (14%) | 32 (44%) | 28 (25%) | 0.0009 |
| Calcium arc 270–314° | 16 (28%) | 18 (25%) | 40 (36%) | 0.25 |
| Calcium arc 225–269° | 10 (17%) | 12 (17%) | 24 (21%) | 0.67 |
| Calcium arc 180–224° | 24 (41%) | 10 (15%) | 20 (18%) | 0.0005 |
| Major axis diameter after using CB (mm) | 2.56 ± 0.32 | 2.63 ± 0.42 | 2.67 ± 0.41 | 0.22 |
| Minor axis diameter after using CB (mm) | 1.99 ± 0.28 | 1.99 ± 0.28 | 1.95 ± 0.29 | 0.52 |
| Lumen area after using CB (mm2) | 4.08 ± 0.87 | 4.21 ± 1.08 | 4.17 ± 1.15 | 0.80 |
| Cracked calcium thickness (µm) | N/A | 465 ± 162 ( | 387 ± 312 ( | 0.08 |
| Final lumen area (mm2) | 6.43 ± 1.31 | 6.38 ± 1.36 | 6.66 ± 1.51 | 0.38 |
| Symmetry index | 0.86 ± 0.09 | 0.84 ± 0.08 | 0.86 ± 0.08 | 0.45 |
| Final lumen area/estimated vessel area (%) | 51.2 ± 12.4 | 50.0 ± 12.2 | 56.9 ± 13.0 | 0.0005 |
Data are presented as number (%) or mean ± standard deviation, unless otherwise noted. CB, cutting balloon; OFDI, optical frequency domain imaging.
Figure 2Lumen area expansion ratio between before ballooning and after stenting. (a) Lumen area expansion ratio between before ballooning and after stenting (all analyzed frames (n = 242)). Type 0, 196% (interquartile range (IQR), 163–244), type 1, 210% (IQR, 174–244), and type 2, 237% (IQR, 203–294). (b) Lumen area expansion ratio between before ballooning and after stenting according to the degrees of calcium arc. 315–360° calcium sections: type 0, 135% (IQR, 110–231); type 1, 197% (IQR, 167–241); and type 2, 242% (IQR, 220–368)). 270–314° calcium sections (type 0, 207% (IQR, 175–247); type 1, 214% (IQR, 177–255); and type 2, 227% (IQR, 200–280)). 225–269° calcium sections (type 0, 200% (IQR, 182–236); type 1, 199% (IQR, 175–220); and type 2, 232% (IQR, 212–334)). 180–224° calcium sections (type 0, 198% (IQR, 157–247); type 1, 228% (IQR, 189–265); and type 2, 231% (IQR, 201–269)).
Figure 3Receiver operating characteristic analysis for the prediction of type-2 cracks after balloon angioplasty. AUC, areas under the curve.
Figure 4Representative cases of those who underwent optical frequency domain imaging (OFDI)-guided percutaneous coronary intervention (PCI) for severely calcified coronary disease. (a–d) A 69-year-old male with LAD lesion. Serial OFDI images obtained the same cross-section. (a) Initial OFDI image showed all rounded calcified plaque. (b) Postrotational atherectomy using a 1.5 mm and 2.0 mm burr; the calcium almost disappeared within the circumference (yellow arrowhead). The lumen area was 3.5 mm2 and the lumen perimeter 6.6 mm. (c) Postballooning using a cutting balloon (diameter, 3.0 mm; dilatation atmosphere, 10 atm; perimeter, 10.2 mm). Blue arrowheads show the medial dissection between calcified plaque and vessel wall. (d) Final OFDI image after stenting (DES diameter was 3.5 mm). The lumen area was 8.1 mm2, and the expansion ratio (final lumen area/lumen area before ballooning) was 231%. (e–g) A 74-year-old female with LAD lesion. Serial OFDI images obtained the same cross-section. Fast view catheter (TERUMO) did not pass the lesion. Thus, there was no initial OFDI image before rotational atherectomy. (e) Postrotational atherectomy using a 1.5 mm and 2.0 mm burr; the lumen was totally surrounded by thick calcium. The lumen area was 3.3 mm2 and the lumen perimeter 6.4 mm. (f) Postballooning using a cutting balloon (diameter, 2.25 mm; dilatation atmosphere, 8 atm; perimeter, 7.3 mm). The sheet calcium was cracked without medial dissection (blue arrowhead). (g) Final OFDI image after stenting (DES diameter was 2.5 mm). The lumen area was 4.6 mm2 and the expansion ratio (final lumen area/lumen area before ballooning) was 139%. DES, drug-eluting stent; LAD, left anterior descending artery; OFDI, optical frequency domain imaging; PCI, percutaneous coronary intervention.